They decreased the expression of IL-6 and TNF-α and the production of iNOS, while anti-inflammatory IL-10 was upregulated both in hypoxia-treated BV2 cells and a retinopathy mouse model through inhibition of the NF-κB pathway [61]. The gene discussed is NFKB1; the disease is retinal disorder.